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Background: Adipose tissue transplantation has the benefit of providing both regenerative and aesthetic outcomes in breast cancer treatment.
However, the transplanted tissue can stimulate the growth of residual cancer cells.
Objectives: The aim of this study is to identify the interactions between adipose tissue cell subpopulations and human cancer cell lines.
Methods: Intact adipose tissue from lipofilling procedures as well as fibroblasts derived from adipose tissue, were cocultured in the presence of MDA-
MB-231, MCF-7 e ZR-75-1 breast cancer cell lines. The influence on cancer cell lines of fibroblasts, induced to differentiate into specific adipocytes, was also
assayed.
Results: All cancer cell lines displayed a significant increase in proliferation rate when cocultured in the presence of either intact adipose tissue or
induced adipocytes. To a lesser extent, uninduced fibroblasts stimulate breast cancer cell proliferation.
Conclusions: Recent studies have shown that the microenvironment surrounding breast cancer cells may stimulate growth and promote progression of
residual cancer cells when surgery is performed on the main tumor mass. Accordingly, the graft of adipose tissue could potentially promote or accelerate
the development of a subclinical tumor or support its locoregional recurrence. Our data suggest that adipocytes have a remarkable influence on the prolif-
eration of cancer cell lines. The oncological safety of the lipofilling procedure outcome is still debated; thus, further studies and consistent follow-up exami-
nation are needed.
Accepted for publication September 4, 2015.
In breast surgery, adipose tissue transplant is applied in aes-
thetic tissue augmentation, in congenital defects, in the im-
provement of breast profile defects after conservative surgery,
in the treatment of radiotherapy sequelae, in implant coverage
after postmastectomy reconstructive surgery, and to reduce
the number of more invasive reconstructive procedures such
as myocutaneous flaps.1,2 As a result of adipose tissue’s well-
known regenerative potential and capability to improve tissue
quality, adipose tissue transplants are applied in oncologic
breast surgery, because stem cells and mesenchymal progeni-
tors (human adipose-derived stem cells) release proangio-
genic factors.3 Because adipose tissue essentially consists of
adipocytes and stromal fibroblasts, is metabolically active,
and secretes several cytokines and growth factors, it does not
simply behave as an inert filler and could ultimately influence
the microenvironment and recurrence of cancer.4-6 Recently
the concept of a potential role of the microenvironment of
cancer surrounding the epithelial tumors in the promotion of
tumor cell growth has been introduced.7-11 Thus, transplanted
adipocytes and/or stromal fibroblasts may contribute to
accelerating tumor growth in vivo.
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Recent studies have investigated the influence of adipose
stem cells and mature adipocytes on the proliferation of re-
sidual cancer cells in the tumor bed.12 Any procedure that
may transfer these cell types into the lesion site could poten-
tially stimulate residual cells in the tumor bed, thus enhanc-
ing the risk of cancer recurrence. However, no clinical
studies have currently shown significant results supporting
the role of an autologous adipose tissue transplant in cancer
relapse, and the biological mechanism remains unclear.
Studies conducted with the murine preadipocytes line
3T3 - L1 have shown that these cells can promote the
growth and survival of breast cancer cell lines and that
the conditioned medium derived from cultured adipocytes
helps the invasiveness of tumor cells.12-14 Additionally,
both fibroblasts and adipocytes have proved beneficial
to the growth of the tumor, as well as their conditioned
media. Furthermore, in vitro differentiated human breast prea-
dipocytes increased the motility of tumor cells, although the
mechanism of doing so has not been determined.13,14
Another study utilized murine 3T3 - F442A preadipo-
cytes cocultured in a transwell system with human and
murine breast cancer cell lines: in both cases, an increase
in tumor invasiveness was observed, leading to the as-
sumption that the factors released by preadipocytes may
cause this effect.15 Moreover, studies on the proliferative
capability of mesenchymal fat stem cells conclude that
these cells do not possess telomerase activity, typical of
cancer cells behavior, and that therefore they do not
display any aptitude for spontaneous transformation.16-18
In this study, we have isolated two subpopulations of
cells from lipoaspirates: adipose-derived mesenchymal
stem cell components and progenitors, and mature adipo-
cytes, to provide the basis for to better comprehend the
possible supportive role of the stroma in breast cancer
relapse during reconstructive surgery.
METHODS
Patients, Primary Cells, and Cell Lines
The study protocol was evaluated and approved by the
Institutional Ethics Committee of the IRCCS-AOU San
Martino-IST in Genoa, Italy. The population of the study
(7 cases) was recruited over a 5-month period from October
2014 to February 2015. The data were collected anony-
mously and included features of the patient (age, gender,
medical history), aesthetic defects, characteristics of the
tumor in oncologic patients (histology, receptor status).
A power analysis was not performed. We utilized a limited
set of samples, and the results that we obtained were very
consistent. For every sample, we performed three different
experiments in duplicate. The selection criteria were
gender (only female), had previous oncologic surgery
for breast cancer (mastectomy/conservative surgery) or
degenerative diseases, and had no comorbidities. All pa-
tients provided their written informed consent before their
enrollment in the study.
Adipose tissue samples (10 mL) were obtained as by-
products of liposuction procedures harvested from elective
donor sites such as the internal regions of the knees, the
hips, and the gluteus. A 3-mm Coleman cannula connected
to a 10-mL Luer Lock syringe was utilized, after we utilized
Klein solution infiltration (lidocaine 30 mL, epinephrine
1 mg/mL, 1:1000; lactated Ringer’s 1 L) and aspiration was
carried out manually. Lipoaspirate samples were processed
no later than 12 hours after harvest.
Adipose tissue samples were rinsed twice with phosphate
buffer saline solution (PBS, Sigma), centrifuged at 1000 rpm
for 1 minute to eliminate residual Klein’s solution; the
aqueous phase was discarded, and the adipose tissue was di-
gested with Collagenase I (400 U/mL; Biochrom cat. CI-22)
for 60 minutes at 37°C with constant agitation. Samples
were then centrifuged at 1200 rpm for 5 minutes, superna-
tants were discarded, and pellets, containing stromal fibro-
blasts, were seeded in Coon’s-F12 medium (Biochrom, cat.
F9149) supplemented with 10% fetal bovine serum (FBS,
Euroclone, cat ECS0180L) and 1% Glutamine (Gibco cat.
25030-024) in 100 mm Petri dishes. Every other day, non-
adherent cells were removed and fresh medium was added
to the culture dishes. When adherent cells reached 70%
confluence, they were harvested through trypsinization,
counted, and seeded in a 24-well plate at a concentration of
25,000 cells/well and subsequently induced to differentiate
them into adipocytes by supplementation of the Adipogenic
Induction Medium (Lonza, cat. PT-3102B) combined with
humanmesenchymal stem cell (hMSC) Adipogenic Induction
Single Quote (Lonza, cat. PT-4135) for 3 weeks, according to
the manufacturer’s protocols.
Three breast cancer cell lines—ZR-75-1 (estrogen-
responsive: ER+), MCF7 (ER+), andMDA-MB-231 (estrogen
unresponsive: ER-)—were obtained from Interlab Cell Line
Collection (ICLC, IRCCS-AOU San Martino-IST, Genoa, Italy)
and maintained in RPMI 1640 medium (Euroclone, cat.
ECB9006L) supplemented with 10% fetal bovine serum (FBS,
Euroclone, cat. ECS0180L) and 1% Glutamine (Gibco, cat.
25030-024).
Coculture Experiments
We investigated the effects of unfractionated adipose tissue,
and induced and non-induced fibroblasts, on the prolifera-
tion of breast cancer cells. Therefore all experiments were
performed considering a paracrine effect of adipose-derived
cells on breast cancer cell lines. With this purpose in mind,
we utilized a Transwell system, which provides a contempo-
rary cultivation but avoids any physical contact between the
two cell populations, thus illustrating the effects of secreted
soluble factors.
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Cocultures of breast cancer cell lines and unfractionated
adipose tissues of seven samples were performed. Breast
cancer cells were briefly seeded in a 24-well plate at the con-
centration of 5000 cells/well, and 0.5 mL of fresh adipose
tissuewere placed in the corresponding transwells. Cancer cell
growth was evaluated by the AlamarBlue assay (Invitrogen,
cat. DAL1100) after 48 hours.
Either induced or noninduced adipose-derived fibro-
blasts were cocultured with each of the three breast cancer
cell lines. Fibroblasts were briefly seeded in a 24-well plate
at the concentration 25,000 cells/well. To induce fibro-
blasts to differentiate into adipocytes, we utilized the
Adipogenic Induction Medium (Lonza, cat. PT-3102B)
combined with the hMSC Adipogenic Induction Single
Quote (Lonza, cat. PT-4135). At the end of the differentia-
tion protocol, 5000 breast cancer cells were seeded in each
transwell and placed over the wells containing induced fi-
broblasts. Cancer cell proliferation was evaluated through
the AlamarBlue assay at 48 hours after seeding. This
method permits the evaluation of cell proliferation in the
course of time on the same sample without causing cell
death, thus decreasing variations among different samples.
All samples were tested in duplicate, and each experiment
was repeated three times.
Cell-specific Response Test
To evaluate whether the increase in proliferation was spe-
cifically caused by adipocytes and adipose tissue–derived
cells or it occurred with other cell types, all breast cancer
cell lines were cocultured in the presence of two different
strains of human bone marrow stromal cells (hBMSC;
Lonza) using the same Transwell system. Cancer cell
proliferation was measured at 48 hours through the
AlamarBlue assay. All samples were tested in duplicate,
and each experiment was repeated three times.
Statistical Analysis
In order to evaluate the statistical significance of our results,
we performed unpaired t test analysis with 95% CI, using
the PRISM software 3.0cx version (Mac version). This test
permits the comparison of the mean values of experiments.
A P value was considered significant when>.05.
RESULTS
Tissue Samples, Primary Cells, and
Adipogenic Induction
The mean age of the patients recruited, all of whom were
women, was 49.2 years (range, 39-54 years). After 7 days in
culture, lipoaspirate-derived fibroblasts reached an average
value of 0.45± 0.19×106 cells per each mL of lipoaspirate
utilized. Considering an approximated doubling time of 24
hours, we estimated a frequency of 6×103 fibroblast-like
cells in the original samples. The cells displayed the typical
fibroblast-like phenotype (Figure 1A), and a pre-adipocyte
phenotype with lipid droplets filling the cytoplasm when
they were induced to differentiation (Figure 1B).
Cocultures of Adipocytes and Breast Cancer
Cells
In the coculture system, an average increase in the prolifera-
tion rate of 2.31 folds in the three breast cancer cell lines was
Figure 1. (A) Stromal vascular fraction display in culture a rather homogeneous phenotype with most of the cells displaying an
elongated, bipolar, fibroblast-like phenotype. (B) After 18 days of stimulation in adipogenic conditions, an important percentage of
stromal vascular fraction evidenced a cytoplasmic accumulation of lipid droplets suggesting the shift vs an adipogenic phenotype.
Bar= 5 µm.
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observed when the lines were cocultured in the presence of
undigested adipose tissue compared with control breast
cancer cell lines alone (Figure 2). The increase in the prolifer-
ation rate was statistically significant in all breast cancer
cell lines (P values: MDA-MB-231= .0053; MCF7= .0116;
ZR-75-1= .0017).
Induced fibroblasts significantly stimulated the prolifera-
tion of breast cancer cells, but to a lesser extent regarding
total adipose tissue, with an average increase of approxi-
mately 1.46 folds. (Figure 3A). The increase in the prolifera-
tion rate in the presence of induced fibroblasts was
statistically significant in all breast cancer cell lines (P values:
MDA-MB-231= .0062; MCF7= .0109; ZR-75-1= .0035).
Cocultures with noninduced fibroblasts displayed an average
increase in proliferation rate of 1.21 (P values: MDA-MB-
231= .0115; MCF7= .0449; ZR-75-1= .0194) (Figure 3B).
Furthermore, to evaluate the specificity of fat tissue–
derived cell stimulation, we utilized hBMSC as a source of
fibroblasts unrelated to tissue. In this case, we did not
observe any significant variation in the proliferation of
breast cancer cell lines (Figure 4).
DISCUSSION
Adipocytes constitute most of the fat tissue, but there are
also other cell types including fibroblasts and preadipocytes
at a different maturation stage. In this study, considering
that the same pattern of cell populations is also represented
in lipoaspirate samples, we wanted to identify which cell
component would hold a significant effect in influencing
the proliferation of breast cancer cells.
It is well known that the different components of fat tissue
secrete a significant variety of signaling molecules.19-21 our
study was aimed at identifying interactions between adipose
tissue cell subpopulations and human cancer cell lines. The
study was conducted only on human samples in all of our ex-
periments, trying to reproduce the interactions operating on
humans, whereas most previous studies reported in the liter-
ature analyzed adipocytes on animal models.22-24 Moreover,
a subpopulation analysis was performed to identify which
cellular component in lipoaspirates could be responsible for
the eventual adverse effects.
We initially verified the influence of total unfractionated
lipoaspirate on the proliferation of cancer cells. To this end,
we cocultured unprocessed lipoaspirates with three differ-
ent breast cancer cell lines, and we observed that the prolif-
eration rate was enhanced, with an average value of 2.31
folds for all cell lines tested. This evidence is in agreement
with the previous results of Dirat and coworkers25 reporting
that cancer-associated adipocytes (CAA), as well as cancer
associated fibroblasts (CAF), can promote tumor growth.26
Figure 2. The proliferation of breast cancer cell lines when co-
cultured for 48 hours in the presence of unprocessed lipoaspi-
rates vs breast cancer cell lines alone (P values:
MDA-MB-231= .0053; MCF7= .0116; ZR-75-1= .0017).
Each bar represents the average of three separate experiments
performed in duplicate on seven different samples.
Figure 3. The proliferation of breast cancer cell lines when cocultured for 48 hours in the presence of: (A) induced adipocytes vs
breast cancer cell lines alone; (B) noninduced adipocytes vs breast cancer cell lines alone. Each bar represents the average of three
separate experiments performed in duplicate on seven different samples. (P values: (A) MDA-MB-231= .0062; MCF7= .0109;
ZR-75-1= .0035; (B) MDA-MB-231= .0115; MCF7= .0449; ZR-75-1= .0194).
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To identify the influence of the different components of
adipose tissue, we cocultured either uninduced fibroblasts
or fibroblasts induced to adipocytes with breast cancer
cells. Fibroblasts induced to adipocytes were able to
enhance breast cancer cell proliferation on a significant
46% average on all cell lines utilized. Uninduced fibroblasts
displayed a lower stimulation on cancer cell proliferation
(21%). Unrelated fibroblasts, derived from bone marrow,
did not significantly influence cancer cell proliferation, sug-
gesting a specificity of the paracrine effect of adipose tissue
cells. It is otherwise true that a potential limitation of our
study is that the effects were observed in a controlled
system in vitro, which might not completely reflect the mi-
croenvironment present in human organisms, even though
it is simultaneously close to the real scenario. Moreover,
the lack of power analysis on population recruitment could
be a further limitation of our study.
Some authors demonstrated that not only breast cancer
is influenced by adipocytes, but also skin cancer such as
melanoma is affected, and it showed an increase in the pro-
liferation of cells.27
However, from a clinical point of view, the oncological
role of the transplanted adipose tissue in promoting local
recurrence has not yet been clarified. Many authors have
investigated the eventual increase in breast cancer occur-
rence and/or recurrence,28-31 but many studies have limita-
tions in patients enrollment, follow-up time, and statistical
significance.32,33 Petit et al demonstrated an increased risk
of recurrence in intraepithelial neoplasia, this increased
risk was not observed in other types of breast cancer.34
Riggio et al concluded that in stage 1 of the tumor, node,
metastases (TNM) classification, the risk is low, and in
stage 2, local failure is not significantly higher.6
International guidelines for the lipofilling procedure
propose that when the risk of recurrence is higher (as in
partial breast removal), fat grafting should be performed
not sooner than 3-5 years after the surgery. Furthermore in
patients with positive familial history or genetic alteration
in BRCA1/2 genes, it should be mandatory that fat grafting
be avoided.35-37
Future perspectives of our study could be represented by
grafting procedures in animal models that take advantage
of harvested fat tissue that is depleted of specific cell sub-
populations, potentially promoting cancer proliferation.38
CONCLUSION
An increased proliferation of breast cancer cell lines has
been observed in all types of cocultures, demonstrating that
there is a significant effect related to adipose tissue pres-
ence. It is evident that clinicians should consider this evi-
dence when programming an intervention for patients
subjected to oncological treatments. Therefore, it is neces-
sary to make a careful selection of patients who are suitable
for the intervention and to wait an adequate amount of
time between surgery and the first fat grafting treatment,
especially after a conservative surgery. Finally, it is neces-
sary to perform a careful follow-up to monitor the oncologi-
cal safety.
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